Home > Riviste > The Journal of Cardiovascular Surgery > Fascicoli precedenti > The Journal of Cardiovascular Surgery 2011 February;52(1) > The Journal of Cardiovascular Surgery 2011 February;52(1):133-8

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

THE JOURNAL OF CARDIOVASCULAR SURGERY

Rivista di Chirurgia Cardiaca, Vascolare e Toracica


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,179


eTOC

 

REVIEWS  CARDIAC SECTION


The Journal of Cardiovascular Surgery 2011 February;52(1):133-8

Copyright © 2011 EDIZIONI MINERVA MEDICA

lingua: Inglese

Clinical management of doxorubicin-induced heart failure

Christiansen S.

Department of Cardiac Surgery, UK-SH, Campus Lübeck, Germany


PDF  


Doxorubicin-induced heart failure is a rare but serious illness due to the well-known treatment difficulties. Prevention strategies have not demonstrated the expected success and unfortunately, this specific type of heart failure does not respond well to the usual medical therapy as other kinds of heart failure. Therefore, surgical procedures may be necessary in some patients. Cardiac transplantation is performed in most cases but it requires the cure of the neoplastic disease. This usually requires a recurrence-free interval of several years which is associated with a high attrition rate in these patients due to their cardiac disease. Therefore, ventricular assist devices were implanted in selected patients. This review presents the most common procedures and discusses their efficacy as well as their clinical applicability.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail

stefanchristiansen@arcor.de